Cargando…

1,25-OH(2) vitamin D(3) and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL)

In acute lymphoblastic leukemia (ALL), steroid resistance and hypovitaminosis D are both associated with a poor prognosis. We show that methylprednisolone, calcitriol and the AKT-inhibitor MK-2206 have a synergistic effect on the apoptosis of steroid resistant T-ALL cells. Compared to methylpredniso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pistor, Maximilian, Schrewe, Lisa, Haupeltshofer, Steffen, Miclea, Andrei, Faissner, Simon, Chan, Andrew, Hoepner, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993358/ https://www.ncbi.nlm.nih.gov/pubmed/29892547 http://dx.doi.org/10.1016/j.lrr.2018.01.003

Ejemplares similares

Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity
por: Miclea, Andrei, et al.
Publicado: (2017)

Vitamin D and 1,25(OH)(2)D Regulation of T cells
por: Cantorna, Margherita T., et al.
Publicado: (2015)

Antidepressants differentially related to 1,25-(OH)(2) vitamin D(3) and 25-(OH) vitamin D(3) in late-life depression
por: Oude Voshaar, R C, et al.
Publicado: (2014)

MON-LB74 The Problem of Measuring 1,25(OH)2 Vitamin D in Patients With High Levels of 25(OH) Vitamin D
por: Vieira, Jose Gilberto, et al.
Publicado: (2020)

Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019)

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis
por: Hoepner, Robert, et al.
Publicado: (2019)

A Brief Review of the Effects of Vitamin D on Multiple Sclerosis
por: Miclea, Andrei, et al.
Publicado: (2020)

Vitamin D (1,25(OH)(2)D3) induces α-1-antitrypsin synthesis by CD4(+) T cells, which is required for 1,25(OH)(2)D3-driven IL-10
por: Dimeloe, Sarah, et al.
Publicado: (2019)

Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019)

The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency
por: Zielińska, Anna, et al.
Publicado: (2021)

Vitamin D and the Ability to Produce 1,25(OH)(2)D Are Critical for Protection from Viral Infection of the Lungs
por: Arora, Juhi, et al.
Publicado: (2022)

Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study
por: Miclea, Andrei, et al.
Publicado: (2019)

Does Sevelamer Hydrochloride (Renagel) Influence 25(Oh)D3 and 1,25(Oh)2D3 Level in Haemodialysis Patients?
por: Strózecki, Pawel, et al.
Publicado: (2005)

25(OH)D(3) and 1.25(OH)(2)D(3) inhibits TNF-α expression in human monocyte derived macrophages
por: Rafique, Aisha, et al.
Publicado: (2019)

Circulatory 25(OH)D and 1,25(OH)(2)D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
por: Ogura, Hiromu, et al.
Publicado: (2021)

25(OH)D-but not 1,25(OH)(2)D–Is an independent risk factor predicting graft loss in stable kidney transplant recipients
por: Zeng, Shufei, et al.
Publicado: (2023)

1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)(2)D(3) in NSCLC Treatment
por: Upadhyay, Santosh Kumar, et al.
Publicado: (2013)

Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity
por: Pletz, Mathias W, et al.
Publicado: (2014)

Increased 1,25(OH)(2)-Vitamin D Concentrations after Energy Restriction Are Associated with Changes in Skeletal Muscle Phenotype
por: Vidal, Angela, et al.
Publicado: (2021)

The metabolism of 1,25(OH)(2)D(3) in clinical and experimental kidney disease
por: Turner, Mandy E., et al.
Publicado: (2022)

The Paracrine Feedback Loop Between Vitamin D(3) (1,25(OH)(2)D(3)) and PTHrP in Prehypertrophic Chondrocytes
por: Bach, Frances C, et al.
Publicado: (2014)

The Vitamin D Analogue ED71 but Not 1,25(OH)(2)D(3) Targets HIF1α Protein in Osteoclasts
por: Sato, Yuiko, et al.
Publicado: (2014)

Expression of TXNIP in Cancer Cells and Regulation by 1,25(OH)(2)D(3): Is It Really the Vitamin D(3) Upregulated Protein?
por: Abu el Maaty, Mohamed A., et al.
Publicado: (2018)

Vitamin D(3) Metabolic Enzymes in the Porcine Uterus: Expression, Localization and Autoregulation by 1,25(OH)(2)D(3) In Vitro
por: Grzesiak, Malgorzata, et al.
Publicado: (2022)

Effects of 1,25(OH)(2)D(3) and 25(OH)D(3) on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy
por: van der Meijden, K., et al.
Publicado: (2016)

The Association Between Vitamin D and Multiple Sclerosis Risk: 1,25(OH)(2)D(3) Induces Super-Enhancers Bound by VDR
por: Lu, Ming, et al.
Publicado: (2019)

The Atrophic Effect of 1,25(OH)(2) Vitamin D(3) (Calcitriol) on C2C12 Myotubes Depends on Oxidative Stress
por: Raiteri, Tommaso, et al.
Publicado: (2021)

The Effect of Vitamin D Prophylaxis on 25-OH Vitamin D Levels in Children
por: Gül, İhsan, et al.
Publicado: (2021)

25(OH)Vitamin D Deficiency and Calcifediol Treatment in Pediatrics
por: Castano, Luis, et al.
Publicado: (2022)

Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D
por: Sollid, Stina T, et al.
Publicado: (2016)

Recruitment, augmentation and apoptosis of rat osteoclasts in 1,25-(OH)(2)D(3) response to short-term treatment with 1,25-dihydroxyvitamin D(3)in vivo
por: Miao, Dengshun, et al.
Publicado: (2002)

Protective role of 1,25(OH)(2)vitamin D(3) in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice
por: Zhao, Hongwei, et al.
Publicado: (2012)

Promoting effect of 1,25(OH)(2) vitamin D(3) in osteogenic differentiation from induced pluripotent stem cells to osteocyte-like cells
por: Kato, Hiroshi, et al.
Publicado: (2015)

Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)(2)D(3)
por: Kägi, Larissa, et al.
Publicado: (2018)

In Vitro Differentiation of Preosteoblast-Like Cells, MC3T3-E1, to Adipocytes Is Enhanced by 1,25(OH)(2) Vitamin D(3)
por: Pendleton, Elisha, et al.
Publicado: (2017)

Vitamin D (1,25-(OH)(2)D(3)) Improves Endothelial Progenitor Cells Function via Enhanced NO Secretion in Systemic Lupus Erythematosus
por: Huang, Zhenhua, et al.
Publicado: (2020)

1,25-(OH)(2)D(3)/Vitamin D receptor alleviates systemic lupus erythematosus by downregulating Skp2 and upregulating p27
por: Liu, Dan, et al.
Publicado: (2019)

Association of Dietary Vitamin D Intake, Serum 25(OH)D(3), 25(OH)D(2) with Cognitive Performance in the Elderly
por: Wang, RuTong, et al.
Publicado: (2021)

1,25(OH)(2)D(3) Promotes the Efficacy of CD28 Costimulation Blockade by Abatacept
por: Gardner, David H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5l822nu5gkok20fmnmto3eq8jn